MedPath

GRADIENT DENERVATION TECHNOLOGIES

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 OUS Study)

Not Applicable
Recruiting
Conditions
Pulmonary Hypertension
First Posted Date
2024-07-11
Last Posted Date
2025-03-05
Lead Sponsor
Gradient Denervation Technologies
Target Recruit Count
20
Registration Number
NCT06495970
Locations
🇪🇸

Hospital Clínico Universitario de Valencia, Valencia, Spain

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

Not Applicable
Recruiting
Conditions
Heart Failure
Group 2 Pulmonary Hypertension
Interventions
Device: Gradient Denervation System
First Posted Date
2023-09-25
Last Posted Date
2025-03-05
Lead Sponsor
Gradient Denervation Technologies
Target Recruit Count
30
Registration Number
NCT06052072
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

🇺🇸

Duke University, Durham, North Carolina, United States

🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

and more 3 locations

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension

Not Applicable
Active, not recruiting
Conditions
Heart Failure Patients With Pulmonary Hypertension
Interventions
Device: Gradient Denervation System
First Posted Date
2023-07-18
Last Posted Date
2025-03-05
Lead Sponsor
Gradient Denervation Technologies
Target Recruit Count
5
Registration Number
NCT05951166
Locations
🇬🇪

Israeli-Georgian Medical Research Clinic Helsicore, Tbilisi, Georgia

🇬🇪

Tbilisi Heart Clinic, Tbilisi, Georgia

© Copyright 2025. All Rights Reserved by MedPath